Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course vs. Standard Antibiotic Therapy for Pulmonary Infiltrates in the ICU
NCT00410527Phase 4Completed
- Sponsor
- National Institutes of Health
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of meropenem in bacterial infection, sponsored by National Institutes of Health. Started Aug 2006; status: completed.
02
Drugs
meropenem
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT00410527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00410527.